S&P 500 (NYSE:SPY) component PerkinElmer, Inc. (NYSE:PKI) will unveil its latest earnings on Thursday, November 3, 2011. PerkinElmer provides technology, services, and solutions to the environmental monitoring, diagnostics, academic research, and safety security markets.

PerkinElmer, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 39 cents per share, a rise of 25.8% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 24.8% versus last year to $1.66.

Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 2 cents, reporting profit of 42 cents per share against a mean estimate of net income of 40 cents per share.

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Wall St. Revenue Expectations: Analysts are projecting a rise of 12% in revenue from the year-earlier quarter to $469.6 million.

Analyst Ratings: Analysts seem relatively indifferent about PerkinElmer with five of eight analysts surveyed maintaining a hold rating.

A Look Back: In the second quarter, profit fell 50.5% to $28.6 million (25 cents a share) from $57.6 million (49 cents a share) the year earlier, but exceeded analyst expectations. Revenue fell 3.7% to $479.5 million from $497.8 million.

Key Stats:

Revenue has fallen in the past four quarters. Revenue declined 3.7% in the first quarter from the year earlier, dropped 7.7% in fourth quarter of the last fiscal year from the year-ago quarter and 4.1% in the third quarter of the last fiscal year.

The company has seen net income fall in each of the last two quarters. Net income dropped 3.6% in the first quarter.

Competitors to Watch: Thermo Fisher Scientific Inc. (NYSE:TMO), Waters Corporation (NYSE:WAT), Beckman Coulter, Inc. (NYSE:BEC), Bruker Corporation (NASDAQ:BRKR), Harvard Bioscience, Inc. (NASDAQ:HBIO), Agilent Technologies Inc. (NYSE:A), Caliper Life Sciences Inc. (NASDAQ:CALP), Becton, Dickinson and Co. (NYSE:BDX), Bio-Rad Laboratories, Inc. (NYSE:BIO), and Sequenom, Inc. (NASDAQ:SQNM).

Stock Price Performance: During September 30, 2011 to October 28, 2011, the stock price had risen $2.47 (12.9%) from $19.14 to $21.61. The stock price saw one of its best stretches over the last year between December 6, 2010 and December 14, 2010 when shares rose for seven-straight days, rising 5.1% (+$1.24) over that span. It saw one of its worst periods between September 14, 2011 and September 22, 2011 when shares fell for seven-straight days, falling 10.7% (-$2.25) over that span. Shares are down $3.91 (-15.3%) year to date.

(Source: Xignite Financials)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!